Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion type Assertion NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_head.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion description "[SPIB remains overexpressed in all cases that lack 1 or 2 of the markers used for BPDC neoplasms (ie, CD4, CD56, TCL1, and CD123).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_provenance.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion evidence source_evidence_literature NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_provenance.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion SIO_000772 23165482 NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_provenance.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion wasDerivedFrom befree-20140225 NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_provenance.
- NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_assertion wasGeneratedBy ECO_0000203 NP827320.RAhx4mGe7DaUmHF5x0uD08UY1HPIYOdXyxX65aADTgK8U130_provenance.